Literature DB >> 17947987

A membrane capture assay for lipid kinase activity.

Zachary A Knight1, Morri E Feldman, Andras Balla, Tamas Balla, Kevan M Shokat.   

Abstract

Phosphoinositide kinases such as PI3-kinase synthesize lipid second messengers that control diverse cellular processes. Recently, these enzymes have emerged as an important class of drug targets, and there is significant interest in discovering new lipid kinase inhibitors. We describe here a procedure for the high-throughput determination of lipid kinase inhibitor IC50 values. This assay exploits the fact that phosphoinositides, but not nucleotides such as ATP, bind irreversibly to nitrocellulose membranes. As a result, the radiolabeled lipids from a kinase assay can be isolated by spotting the crude reaction on a nitrocellulose membrane and then washing. We show that diverse phosphoinositide kinases can be assayed using this approach and outline how to perform the assay in 96-well plates. We also describe a MATLAB script that automates the data analysis. The complete procedure requires 3-4 h.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17947987      PMCID: PMC2919233          DOI: 10.1038/nprot.2007.361

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  31 in total

Review 1.  Features of selective kinase inhibitors.

Authors:  Zachary A Knight; Kevan M Shokat
Journal:  Chem Biol       Date:  2005-06

2.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

3.  Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

Authors:  Montserrat Camps; Thomas Rückle; Hong Ji; Vittoria Ardissone; Felix Rintelen; Jeffrey Shaw; Chiara Ferrandi; Christian Chabert; Corine Gillieron; Bernard Françon; Thierry Martin; Denise Gretener; Dominique Perrin; Didier Leroy; Pierre-Alain Vitte; Emilio Hirsch; Matthias P Wymann; Rocco Cirillo; Matthias K Schwarz; Christian Rommel
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

4.  Cloning and characterization of a 92 kDa soluble phosphatidylinositol 4-kinase.

Authors:  T Nakagawa; K Goto; H Kondo
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

5.  Essential role for the p110delta phosphoinositide 3-kinase in the allergic response.

Authors:  Khaled Ali; Antonio Bilancio; Matthew Thomas; Wayne Pearce; Alasdair M Gilfillan; Christine Tkaczyk; Nicolas Kuehn; Alexander Gray; June Giddings; Emma Peskett; Roy Fox; Ian Bruce; Christoph Walker; Carol Sawyer; Klaus Okkenhaug; Peter Finan; Bart Vanhaesebroeck
Journal:  Nature       Date:  2004-10-21       Impact factor: 49.962

6.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

7.  Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts.

Authors:  Alexander Gray; Henric Olsson; Ian H Batty; Larisa Priganica; C Peter Downes
Journal:  Anal Biochem       Date:  2003-02-15       Impact factor: 3.365

Review 8.  Physiological concentrations of purines and pyrimidines.

Authors:  T W Traut
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

9.  A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate.

Authors:  L E Rameh; K F Tolias; B C Duckworth; L C Cantley
Journal:  Nature       Date:  1997-11-13       Impact factor: 49.962

10.  Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

Authors:  E Hirsch; V L Katanaev; C Garlanda; O Azzolino; L Pirola; L Silengo; S Sozzani; A Mantovani; F Altruda; M P Wymann
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

View more
  26 in total

1.  Identification of small molecule inhibitors of phosphatidylinositol 3-kinase and autophagy.

Authors:  Thomas Farkas; Mads Daugaard; Marja Jäättelä
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Integrin α9β1 in airway smooth muscle suppresses exaggerated airway narrowing.

Authors:  Chun Chen; Makoto Kudo; Florentine Rutaganira; Hiromi Takano; Candace Lee; Amha Atakilit; Kathryn S Robinett; Toshimitsu Uede; Paul J Wolters; Kevan M Shokat; Xiaozhu Huang; Dean Sheppard
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

3.  INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.

Authors:  Darien E Reed; Kevan M Shokat
Journal:  Mol Cancer Res       Date:  2017-02-14       Impact factor: 5.852

4.  Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB.

Authors:  David Maag; Micah J Maxwell; Douglas A Hardesty; Katie L Boucher; Namrata Choudhari; Adam G Hanno; Jenny F Ma; Adele S Snowman; Joseph W Pietropaoli; Risheng Xu; Phillip B Storm; Adolfo Saiardi; Solomon H Snyder; Adam C Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

5.  A single discrete Rab5-binding site in phosphoinositide 3-kinase β is required for tumor cell invasion.

Authors:  Samantha D Heitz; David J Hamelin; Reece M Hoffmann; Nili Greenberg; Gilbert Salloum; Zahra Erami; Bassem D Khalil; Aliaksei Shymanets; Elizabeth A Steidle; Grace Q Gong; Bernd Nürnberg; John E Burke; Jack U Flanagan; Anne R Bresnick; Jonathan M Backer
Journal:  J Biol Chem       Date:  2019-01-18       Impact factor: 5.157

6.  Direct modification and activation of a nuclear receptor-PIP₂ complex by the inositol lipid kinase IPMK.

Authors:  Raymond D Blind; Miyuki Suzawa; Holly A Ingraham
Journal:  Sci Signal       Date:  2012-06-19       Impact factor: 8.192

7.  Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.

Authors:  Bijay S Jaiswal; Vasantharajan Janakiraman; Noelyn M Kljavin; Subhra Chaudhuri; Howard M Stern; Weiru Wang; Zhengyan Kan; Hashem A Dbouk; Brock A Peters; Paul Waring; Trisha Dela Vega; Denise M Kenski; Krista K Bowman; Maria Lorenzo; Hong Li; Jiansheng Wu; Zora Modrusan; Jeremy Stinson; Michael Eby; Peng Yue; Josh S Kaminker; Frederic J de Sauvage; Jonathan M Backer; Somasekar Seshagiri
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

8.  G protein-coupled receptor-mediated activation of p110β by Gβγ is required for cellular transformation and invasiveness.

Authors:  Hashem A Dbouk; Oscar Vadas; Aliaksei Shymanets; John E Burke; Rachel S Salamon; Bassem D Khalil; Mathew O Barrett; Gary L Waldo; Chinmay Surve; Christine Hsueh; Olga Perisic; Christian Harteneck; Peter R Shepherd; T Kendall Harden; Alan V Smrcka; Ronald Taussig; Anne R Bresnick; Bernd Nürnberg; Roger L Williams; Jonathan M Backer
Journal:  Sci Signal       Date:  2012-12-04       Impact factor: 8.192

9.  Design and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIβ.

Authors:  Florentine U Rutaganira; Melissa L Fowler; Jacob A McPhail; Michael A Gelman; Khanh Nguyen; Anming Xiong; Gillian L Dornan; Brandon Tavshanjian; Jeffrey S Glenn; Kevan M Shokat; John E Burke
Journal:  J Med Chem       Date:  2016-02-26       Impact factor: 7.446

10.  TIPE3 is the transfer protein of lipid second messengers that promote cancer.

Authors:  Svetlana A Fayngerts; Jianping Wu; Camilla L Oxley; Xianglan Liu; Anastassios Vourekas; Terry Cathopoulis; Zhaojun Wang; Jian Cui; Suxia Liu; Honghong Sun; Mark A Lemmon; Lining Zhang; Yigong Shi; Youhai H Chen
Journal:  Cancer Cell       Date:  2014-09-18       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.